CURZA

curza-logo

Curza is a small-molecule therapeutics company that has developed several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. Curza’s lead program is a new class of broad spectrum antibiotics, focused on ESKAPE pathogens and drug-resistant Gram-negative bacteria. Inspired by a natural product, this class targets an unexploited binding site of the bacterial ribosome. With ever increasing reports of resistance to frontline therapies addressing Gram-negative bacteria, there is a critical need for new therapies and new therapies that work in new ways. However, very little can be found in the development pipeline. As a result, Curza’s compounds are addressing a major unmet medical need.

#SimilarOrganizations #People #Financial #Website #More

CURZA

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Address:
Salt Lake City, Utah, United States

Country:
United States

Website Url:
http://www.curza.com

Total Employee:
11+

Status:
Active

Contact:
(617) 575-2202

Total Funding:
24.19 M USD

Technology used in webpage:
Microsoft Exchange Online


Similar Organizations

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.


Current Advisors List

robert-armstrong_image

Robert Armstrong Board Member @ Curza
Board_member
2015-01-01

Current Employees Featured

robert-mooney_image

Robert Mooney
Robert Mooney Founder, CEO @ Curza
Founder, CEO
2021-07-01

john-kozarich_image

John Kozarich
John Kozarich CEO @ Curza
CEO

Founder


robert-mooney_image

Robert Mooney

Investors List

repair-impact-fund_image

Repair Impact Fund

Repair Impact Fund investment in Venture Round - Curza

carb-x_image

CARB-X

CARB-X investment in Grant - Curza

national-institute-of-allergy-and-infectious-diseases_image

National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases investment in Grant - Curza

american-chemical-society_image

American Chemical Society

American Chemical Society investment in Grant - Curza

national-institute-of-general-medical-science_image

National Institute of General Medical Science

National Institute of General Medical Science investment in Grant - Curza

u-s-department-of-veteran-affairs_image

U.S. Department of Veteran Affairs

U.S. Department of Veteran Affairs investment in Grant - Curza

small-business-innovation-research_image

Small Business Innovation Research

Small Business Innovation Research investment in Grant - Curza

u-s-department-of-defense_image

U.S. Department of Defense

U.S. Department of Defense investment in Grant - Curza

clarke-capital-partners_image

Clarke Capital Partners

Clarke Capital Partners investment in Seed Round - Curza

Official Site Inspections

http://www.curza.com Semrush global rank: 5.89 M Semrush visits lastest month: 1.4 K

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.107
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Curza"

Curza - Crunchbase Company Profile & Funding

Curza is a small-molecule therapeutics company that has developed several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. Curza’s lead program is a new class of broad spectrum …See details»

Cūrza Company Profile 2024: Valuation, Funding & Investors

Cūrza General Information Description. Developer of small-molecule therapeutics intended to offer proprietary drugs focused on infectious diseases and oncology. The company's …See details»

Executive Team - Curza

Vice President of Microbiology & New Technologies Dr. Williams is an Associate Professor in the Department of Orthopaedics at the University of Utah and Vice President of New Technologies …See details»

Curza - LinkedIn

Curza | 526 followers on LinkedIn. Small molecule therapeutics R&D company focused on developing new drugs to combat antibiotic resistance | Curza is a small molecule therapeutics development company.See details»

Curza - Funding, Financials, Valuation & Investors - Crunchbase

Curza is a small-molecule therapeutics company provides proprietary drugs focused on infectious diseases and oncology. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»

Curza Company Profile - Office Locations, Competitors, Revenue

Curza Global is a small-molecule therapeutics company that develops drugs for infectious diseases and oncology. It develops ribosomal and antibiofilm antibiotics focused on ESKAPE …See details»

Curza - Org Chart, Teams, Culture & Jobs - The Org

Curza is a small-molecule therapeutics company that has developed several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. Curza’s lead …See details»

Curza - Products, Competitors, Financials, Employees, …

Curza has developed a unique first-in-class series of antimicrobial compounds that kill, disperse and inhibit the growth of bacteria in biofilm communities. Curza’s primary focus is on …See details»

Curza Global, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Curza Global, Inc. of Salt Lake City, UT. Get the latest business insights from Dun & Bradstreet.See details»

Curza Company Profile | Management and Employees List

Find contact information for Curza. Learn about their Business Services market share, competitors, and Curza's email format.See details»

Curza - Crunchbase

Curza is a small-molecule therapeutics company provides proprietary drugs focused on infectious diseases and oncology.See details»

Curza - Company Profile - Tracxn

Curza - US-Based, preclinical stage company developing small molecule therapeutics for Infectious Diseases & Cancer. Raised a total funding of $5.62M over 2 rounds from 1 investor. …See details»

Curza - VentureRadar

Similar Companies: Sun BioPharma USA Privately Held Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and …See details»

Curza - Overview, News & Similar companies | ZoomInfo.com

Jun 25, 2019 Curza Announces $5.25 million Investment from the Novo Holdings REPAIR Impact Fund SALT LAKE CITY, Utah, July 25, 2019 /PRNewswire/ -- Curza, a privately-held …See details»

ABOUT - Curza

Since long before the outbreak of COVID-19, antibiotic resistant bacteria have created a “silent pandemic” that now poses a threat to life as we know it.See details»

Curza - Contacts, Employees, Board Members, Advisors & Alumni

Organization. Curza . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. ... Curza has 1 board …See details»

Press Release 07-25-2019 - curza.com

CŪRZA ANNOUNCES $5.25 MILLION INVESTMENT FROM THE NOVO HOLDINGS REPAIR IMPACT FUNDSALT LAKE CITY, Utah, July 25, 2019 /PRNewswire/ —Cūrza, a privately-held …See details»

NEWS | Curza

Jul 1, 2016 DEPARTMENT OF DEFENSE AWARDS CURZA / UNIVERSITY OF UTAH $2.4 MILLION GRANT Proceeds to Fund Development of Wound VAC Infection Model SALT...See details»

PIPELINE | Curza

We are also developing anti-biofilm antibiotics with various potential applications. Biofilms can cause some of the hardest to treat infections.See details»

linkstock.net © 2022. All rights reserved